Barclays PLC Sells 316,718 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Barclays PLC lessened its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 92.2% during the third quarter, Holdings Channel reports. The fund owned 26,709 shares of the company’s stock after selling 316,718 shares during the period. Barclays PLC’s holdings in U.S. Physical Therapy were worth $2,261,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after buying an additional 61,474 shares during the period. Southernsun Asset Management LLC grew its stake in U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after buying an additional 52,062 shares during the last quarter. Penn Davis Mcfarland Inc. bought a new position in U.S. Physical Therapy in the 3rd quarter valued at about $2,552,000. Finally, Rockefeller Capital Management L.P. boosted its holdings in shares of U.S. Physical Therapy by 18.8% during the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after acquiring an additional 25,393 shares during the period.

Insider Buying and Selling

In related news, Director Nancy Ham sold 1,172 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares in the company, valued at $107,552.64. This represents a 51.31 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the transaction, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. This represents a 10.68 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,412 shares of company stock worth $706,605. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Up 0.5 %

USPH stock opened at $90.26 on Thursday. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The business has a 50-day simple moving average of $91.25 and a 200 day simple moving average of $89.56. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.36 billion, a PE ratio of 96.02, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.95%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

Wall Street Analyst Weigh In

USPH has been the topic of a number of recent research reports. JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Barrington Research reissued an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.